---
type: "Symbol"
title: "XDYY (301130.SZ) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/301130.SZ/topics.md"
symbol: "301130.SZ"
parent: "https://longbridge.com/en/quote/301130.SZ.md"
count: 2
datetime: "2026-03-10T07:08:21.854Z"
locales:
  - [en](https://longbridge.com/en/quote/301130.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301130.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301130.SZ/topics.md)
---

# XDYY (301130.SZ) — Community Discussions

### [下周需要重点规避的解禁潮（2 月 20 日至 2 月 24 日）——骑牛看熊淘金学堂](https://longbridge.com/en/topics/4273868.md)

- Author: [骑牛看熊](https://longbridge.com/en/profiles/6539443.md)
- Datetime: 2023-02-18T02:22:19.000Z
- Comments: 0
- 解禁的股票分为大小非和限售股。持股小于 5% 的非流通股叫小非，持股大于 5% 的非流通股叫大非，承诺在一定的时期内不上市流通或在一定的时期内不完全上市流通的股称为限售股。股票市场有一句名言叫做：“解禁猛于虎！” 虽然解禁只是一个时间窗口，但从解禁当日开始解禁股票流通上市交易，这将会对相应的股票引起重大的影响。骑牛看熊要让大家清楚地知道，大小非解禁的成本是 1 元...

### [2022 年，七成化药企业下跌，仅三成实现市值正增长，新华制药、司太立……](https://longbridge.com/en/topics/3949885.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2023-02-10T01:24:59.000Z
- Comments: 0
- 近年来，小分子药物在 Molnupiravir、Paxlovid 等口服小分子新冠药的引领下重新焕发生机，同时也带动了部分化学制药企业争夺市场的积极性。尽管新冠口服药研发火热，仍未能阻止医药行业的 “寒冬” 侵袭包括化学制药在内的各个细分板块。根据同花顺 i 问财网站显示，截至 2022 年 12 月 30 日，A 股共有 147 家化学制药企业，其中在涨幅方面...

## References

- [XDYY (301130.SZ)](https://longbridge.com/en/quote/301130.SZ.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301130.SZ/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301130.SZ/topics.md)